Condition
Gliosarcoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Gliosarcoma clinical trials that are recruiting, in United States. By phase: Phase 1 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest Gliosarcoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ERAS-801 for operable or recurrent EGFR-altered IDH-wildtype Grade IV glioblastoma or astrocytoma | Phase 1 | Los Angeles, California and 1 other locations | Recruiting | Jul 28, 2025 |
| Testing new drug combinations for glioblastoma treatment | Phase 1 | Los Angeles, California and 10 other locations | Recruiting | Apr 18, 2025 |
| Collecting and preserving glioblastoma tissue during surgery for future research | — | Miami, Florida | Recruiting | Mar 7, 2023 |
| Combining Temozolomide with Abexinostat for Recurrent Glioma Treatment | Phase 1 | Omaha, Nebraska | Recruiting | Jan 26, 2023 |
| Combining Pembrolizumab with M032 for treating recurrent brain tumors | Phase 1/2 | Birmingham, Alabama | Recruiting | Oct 19, 2021 |
All recruiting trials (5)
-
ERAS-801 for operable or recurrent EGFR-altered IDH-wildtype Grade IV glioblastoma or astrocytoma
This trial tests ERAS-801, a brain-penetrant EGFR blocker, to see if it is safe and changes tumor metabolism in adults with resectable or recurrent IDH-wildtype Grade IV glioblastoma or astrocytoma that have EGFR amplification or mutation.
-
Testing new drug combinations for glioblastoma treatment
This study is testing new combinations of drugs to see if they can safely help people with recurrent or newly diagnosed glioblastoma, an aggressive type of brain cancer.
-
Collecting and preserving glioblastoma tissue during surgery for future research
This study is collecting and saving glioblastoma tumor tissue and blood samples during surgery to help researchers learn more about the disease and find better treatments.
-
Combining Temozolomide with Abexinostat for Recurrent Glioma Treatment
This study is testing a new combination of two drugs, Temozolomide and Abexinostat, to see if it can help people with recurrent high-grade gliomas like glioblastoma feel better and manage their condition.
-
Combining Pembrolizumab with M032 for treating recurrent brain tumors
This study is testing a new treatment that combines two therapies, Pembrolizumab and M032, to see if it can help people with recurring brain tumors like glioblastoma feel better when other treatments haven't worked.
Related topics
Quick answers
How many Gliosarcoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.